Autoimmune retinopathy

From WikiMD.org
Jump to navigation Jump to search

Autoimmune Retinopathy

Autoimmune retinopathy (pronunciation: /ˌɔːtoʊˈimjuːn ˌrɛtɪˈnɑːpəθi/), often abbreviated as AIR, is a rare and often underdiagnosed condition that results in progressive vision loss due to the body's immune system mistakenly attacking cells in the retina.

Etymology

The term "autoimmune retinopathy" is derived from the Greek words "autos" (self), "immunos" (immune), and the Latin word "retina" (net), and "pathy" (disease). It refers to a disease where the immune system attacks the self's net-like structure, the retina.

Symptoms

The symptoms of autoimmune retinopathy can vary greatly among individuals. However, common symptoms include night blindness, photopsia (flashes of light), and progressive visual field loss.

Causes

Autoimmune retinopathy is caused by the body's immune system mistakenly producing autoantibodies that target proteins in the retina. This can occur as a result of a systemic autoimmune disease, such as lupus or rheumatoid arthritis, or can occur in isolation.

Diagnosis

Diagnosis of autoimmune retinopathy is often challenging due to its rarity and the lack of specific diagnostic criteria. It typically involves a comprehensive eye examination, including optical coherence tomography and fluorescein angiography, as well as blood tests to detect autoantibodies.

Treatment

Treatment for autoimmune retinopathy typically involves immunosuppressive therapy to reduce the immune system's attack on the retina. This can include corticosteroids, immunoglobulin therapy, or other immunosuppressive drugs.

Related Terms

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski